A Trial of CM-AT in Children With Autism
Public ClinicalTrials.gov record NCT00881452. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase III Randomized Double Blind Placebo Controlled Trial of CM-AT in Children With Autism
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine whether CM-AT is safe and effective in treating the core symptoms of autism.
Study identification
- NCT ID
- NCT00881452
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 182 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 3 Years to 8 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2009
- Primary completion
- May 31, 2011
- Completion
- Aug 31, 2011
- Last update posted
- Apr 18, 2018
2009 – 2011
United States locations
- U.S. sites
- 19
- U.S. states
- 15
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Southwest Autism Research and Resource Center | Phoenix | Arizona | 85006 | — |
| University of California, Davis, M.I.N.D. Institute | Sacramento | California | 95817 | — |
| University of California, San Francisco | San Francisco | California | 94143 | — |
| Neuropsychiatric Research Center of Orange County | Santa Ana | California | 92701 | — |
| Lake Mary Pediatrics | Orange City | Florida | 32763 | — |
| Institute for Behavioral Medicine | Smyrna | Georgia | 30080 | — |
| Alexian Brothers Center for Psychiatric Research | Hoffman Estates | Illinois | 60169 | — |
| Louisiana State University Health Science Center | Shreveport | Louisiana | 71103 | — |
| Saint Peters University Hospital | New Brunswick | New Jersey | 08901 | — |
| Mount Sinai School of Medicine | New York | New York | 10029 | — |
| University of North Carolina | Chapel Hill | North Carolina | 27514 | — |
| Ohio State University | Columbus | Ohio | 43210 | — |
| Oklahoma University Child Study Center | Oklahoma City | Oklahoma | 73117 | — |
| Cyn3rgy Research | Gresham | Oregon | 97030 | — |
| Hershey Medical Center | Hershey | Pennsylvania | 17033 | — |
| Drexel University | Philadelphia | Pennsylvania | 19124 | — |
| University of Pittsburgh | Pittsburgh | Pennsylvania | 15260 | — |
| University of Texas, Houston | Houston | Texas | 77054 | — |
| Westside Medical | Clinton | Utah | 84015 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00881452, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 18, 2018 · Synced Sep 13, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00881452 live on ClinicalTrials.gov.